Irinotecan Hydrochloride 50742-0402
Product NDC
50742-0402- Manufacturer
- Ingenus Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 5, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA206935
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 100 mg/5mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Packaging Options(1)
1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL, GLASS